Switching From One Anti-IL-17 Antibody to Another: On Trying Again or Changing the Target

Saved in:
Bibliographic Details
Published inActas dermo-sifiliográficas (English ed.) Vol. 112; no. 5; pp. 473 - 475
Main Authors Pinilla Martín, B., Sánchez Velázquez, A., Vico Alonso, C., Rivera Díaz, R.
Format Journal Article
LanguageEnglish
Published Elsevier España, S.L.U 01.05.2021
Online AccessGet full text

Cover

Author Sánchez Velázquez, A.
Pinilla Martín, B.
Vico Alonso, C.
Rivera Díaz, R.
Author_xml – sequence: 1
  givenname: B.
  surname: Pinilla Martín
  fullname: Pinilla Martín, B.
  email: belenpinillamartin@gmail.com
– sequence: 2
  givenname: A.
  surname: Sánchez Velázquez
  fullname: Sánchez Velázquez, A.
– sequence: 3
  givenname: C.
  surname: Vico Alonso
  fullname: Vico Alonso, C.
– sequence: 4
  givenname: R.
  surname: Rivera Díaz
  fullname: Rivera Díaz, R.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33307013$$D View this record in MEDLINE/PubMed
BookMark eNp9kM1OwzAQhC1UREvpGyCUF0jw2s0fB6SqolCpUg-UAyfLsTepq9apnADq2-MQQJw47Wj0ze5qLsnA1hYJuQYaAYXkdhdJjbbaR4xCHgGLvHlGRhCnWcggp4M_ekgmTbOjlAIDHnO4IEPOOU0p8BF5ff4wrdoaWwULVx-CtcVgZlsTLlchpF-yqPUpaGuv63aL7s4zwcadusisksYGtQvmW2mrzvFEsJGuwvaKnJdy3-Dke47Jy-JhM38KV-vH5Xy2ChVn0zaUyKiGPM0LqUBRmkgOXOdpqZOcoZQZhxKSQiLnmKg8TnU8TcpMI-OIOsn4mEz7vcrVTeOwFEdnDtKdBFDRlSV2oi9LdGUJYMKbPnbTx45vxQH1b-inGg_c9wD6598NOtEog1ahNg5VK3Rt_r_wCa6UfOo
Cites_doi 10.1111/bjd.17580
10.1080/09546634.2018.1506081
10.1016/j.jaad.2018.01.003
10.2147/JIR.S100940
10.1007/s00403-019-01907-y
10.1111/bjd.15665
10.1016/j.jaad.2017.06.153
10.1002/acr.23738
ContentType Journal Article
Copyright 2020 AEDV
Copyright_xml – notice: 2020 AEDV
DBID 6I.
AAFTH
NPM
AAYXX
CITATION
DOI 10.1016/j.adengl.2019.12.016
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
PubMed
CrossRef
DatabaseTitle PubMed
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate De un anti-IL-17 a otro: dar una segunda oportunidad o cambiar de diana
EISSN 1578-2190
EndPage 475
ExternalDocumentID 10_1016_j_adengl_2019_12_016
33307013
S1578219021000937
Genre Case Reports
GroupedDBID --K
--M
.1-
.~1
0SF
1B1
1P~
1~.
1~5
457
53G
5VS
65R
6I.
7-5
71M
8P~
AACTN
AAEDT
AAEDW
AAFTH
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
ABBQC
ABLVK
ABMAC
ABMZM
ABXDB
ABYKQ
ACDAQ
ACGFS
ACRLP
ADBBV
ADEZE
AEBSH
AEKER
AEVXI
AFCTW
AFKWA
AFRHN
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
AXJTR
BKOJK
BLXMC
BNPGV
EFJIC
EFLBG
EP3
FDB
FEDTE
FIRID
FNPLU
FYGXN
GBLVA
HVGLF
HZ~
J1W
KOM
LCYCR
M41
MO0
N9A
O-L
OAUVE
OB.
OM~
OZT
P-8
P-9
PC.
Q38
ROL
SDF
SES
SPCBC
SSH
SSZ
T5K
Z5R
~G-
AKRWK
NPM
AAXKI
AAXUO
AAYXX
ADVLN
CITATION
ID FETCH-LOGICAL-c324t-ae20d1979bac1c006a313d97fd692eaa831f16bae33e6c957d546f8de23eed683
IEDL.DBID .~1
ISSN 1578-2190
IngestDate Thu Sep 12 17:57:52 EDT 2024
Thu May 23 23:42:27 EDT 2024
Fri Feb 23 02:46:04 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
License This is an open access article under the CC BY-NC-ND license.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c324t-ae20d1979bac1c006a313d97fd692eaa831f16bae33e6c957d546f8de23eed683
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S1578219021000937
PMID 33307013
PageCount 3
ParticipantIDs crossref_primary_10_1016_j_adengl_2019_12_016
pubmed_primary_33307013
elsevier_sciencedirect_doi_10_1016_j_adengl_2019_12_016
PublicationCentury 2000
PublicationDate 2021-05-01
PublicationDateYYYYMMDD 2021-05-01
PublicationDate_xml – month: 05
  year: 2021
  text: 2021-05-01
  day: 01
PublicationDecade 2020
PublicationTitle Actas dermo-sifiliográficas (English ed.)
PublicationTitleAlternate Actas Dermosifiliogr (Engl Ed)
PublicationYear 2021
Publisher Elsevier España, S.L.U
Publisher_xml – name: Elsevier España, S.L.U
References Liu, Lu, Allan, Tang, Tetreault, Chow (bib0030) 2016; 9
Conti, Peccerillo, Amerio, Balato, Bardazzi, Bianchi (bib0015) 2019; 180
Blauvelt, Gooderham, Iversen, Ball, Zhang, Agada (bib0040) 2017; 77
Georganopopoulos, Phung, Ighani, Yeung (bib0005) 2018; 79
Gasslitter, Kirstern, Augustin, Torz, Mrowietz, Eyerich (bib0020) 2019; 311
Organización Mundial de la Salud. Obesidad y sobrepeso. OMS [Accessed 20 December 2020]. Available from
Smith, Jabbar-Lopez, Yiu, Bale, Burden, Coates (bib0025) 2017; 177
Agencia Europea del Medicamento. Ficha Técnica de Talz®. [Accessed 10 November 2019]. Available from
Bokor-Billmann, Schäkel (bib0010) 2019; 30
.
Mease, Roussou, Burmester, Goupille, Gottlieb, Moriarty (bib0045) 2019; 71
Bokor-Billmann (10.1016/j.adengl.2019.12.016_bib0010) 2019; 30
Gasslitter (10.1016/j.adengl.2019.12.016_bib0020) 2019; 311
Liu (10.1016/j.adengl.2019.12.016_bib0030) 2016; 9
10.1016/j.adengl.2019.12.016_bib0050
Conti (10.1016/j.adengl.2019.12.016_bib0015) 2019; 180
10.1016/j.adengl.2019.12.016_bib0035
Georganopopoulos (10.1016/j.adengl.2019.12.016_bib0005) 2018; 79
Mease (10.1016/j.adengl.2019.12.016_bib0045) 2019; 71
Smith (10.1016/j.adengl.2019.12.016_bib0025) 2017; 177
Blauvelt (10.1016/j.adengl.2019.12.016_bib0040) 2017; 77
References_xml – volume: 180
  start-page: 1547
  year: 2019
  end-page: 1548
  ident: bib0015
  article-title: Efficacy and safety of switching to ixekizumab in secukinumab nonresponder psoriatic patients: results from a multicenter experience
  publication-title: Br J Dermatol
  contributor:
    fullname: Bianchi
– volume: 71
  start-page: 367
  year: 2019
  end-page: 378
  ident: bib0045
  article-title: Safety of ixekizumab in patients with psoriatic arthritis: results from a pooled analysis of three clinical trials
  publication-title: Arthritis Care Res (Hoboken)
  contributor:
    fullname: Moriarty
– volume: 30
  start-page: 216
  year: 2019
  end-page: 220
  ident: bib0010
  article-title: No need to change the drug class: ixekizumab following secukinumab-therapy in psoriasis
  publication-title: J Dermatolog Treat
  contributor:
    fullname: Schäkel
– volume: 9
  start-page: 39
  year: 2016
  end-page: 50
  ident: bib0030
  article-title: Generation and characterization of ixekizumab, a humanized monoclonal antibody that neutralizes interleukin-17A
  publication-title: J Inflamm Res
  contributor:
    fullname: Chow
– volume: 177
  start-page: 628
  year: 2017
  end-page: 636
  ident: bib0025
  article-title: British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017
  publication-title: Br J Dermatol.
  contributor:
    fullname: Coates
– volume: 79
  start-page: 155
  year: 2018
  end-page: 157
  ident: bib0005
  article-title: Efficacy and safety of switching to ixekizumab in secukinumab non-responders with plaque psoriasis: a multicenter retrospective study of interleukin (IL)-17A antagonist therapies
  publication-title: J Am Acad Dermatol
  contributor:
    fullname: Yeung
– volume: 311
  start-page: 421
  year: 2019
  end-page: 424
  ident: bib0020
  article-title: Successful intra-class switching among IL-17 antagonists: a multicenter, multinational, retrospective study
  publication-title: Arch Dermatol Res
  contributor:
    fullname: Eyerich
– volume: 77
  start-page: 855
  year: 2017
  end-page: 862
  ident: bib0040
  article-title: Efficacy and safety of ixekizumab for the treatment of moderate-to-severe plaque psoriasis: results through 108 weeks of a randomized, controlled phase 3 clinical trial (UNCOVER-3)
  publication-title: J Am Acad Dermatol
  contributor:
    fullname: Agada
– volume: 180
  start-page: 1547
  year: 2019
  ident: 10.1016/j.adengl.2019.12.016_bib0015
  article-title: Efficacy and safety of switching to ixekizumab in secukinumab nonresponder psoriatic patients: results from a multicenter experience
  publication-title: Br J Dermatol
  doi: 10.1111/bjd.17580
  contributor:
    fullname: Conti
– ident: 10.1016/j.adengl.2019.12.016_bib0050
– volume: 30
  start-page: 216
  year: 2019
  ident: 10.1016/j.adengl.2019.12.016_bib0010
  article-title: No need to change the drug class: ixekizumab following secukinumab-therapy in psoriasis
  publication-title: J Dermatolog Treat
  doi: 10.1080/09546634.2018.1506081
  contributor:
    fullname: Bokor-Billmann
– volume: 79
  start-page: 155
  year: 2018
  ident: 10.1016/j.adengl.2019.12.016_bib0005
  article-title: Efficacy and safety of switching to ixekizumab in secukinumab non-responders with plaque psoriasis: a multicenter retrospective study of interleukin (IL)-17A antagonist therapies
  publication-title: J Am Acad Dermatol
  doi: 10.1016/j.jaad.2018.01.003
  contributor:
    fullname: Georganopopoulos
– volume: 9
  start-page: 39
  year: 2016
  ident: 10.1016/j.adengl.2019.12.016_bib0030
  article-title: Generation and characterization of ixekizumab, a humanized monoclonal antibody that neutralizes interleukin-17A
  publication-title: J Inflamm Res
  doi: 10.2147/JIR.S100940
  contributor:
    fullname: Liu
– ident: 10.1016/j.adengl.2019.12.016_bib0035
– volume: 311
  start-page: 421
  year: 2019
  ident: 10.1016/j.adengl.2019.12.016_bib0020
  article-title: Successful intra-class switching among IL-17 antagonists: a multicenter, multinational, retrospective study
  publication-title: Arch Dermatol Res
  doi: 10.1007/s00403-019-01907-y
  contributor:
    fullname: Gasslitter
– volume: 177
  start-page: 628
  year: 2017
  ident: 10.1016/j.adengl.2019.12.016_bib0025
  article-title: British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017
  publication-title: Br J Dermatol.
  doi: 10.1111/bjd.15665
  contributor:
    fullname: Smith
– volume: 77
  start-page: 855
  year: 2017
  ident: 10.1016/j.adengl.2019.12.016_bib0040
  article-title: Efficacy and safety of ixekizumab for the treatment of moderate-to-severe plaque psoriasis: results through 108 weeks of a randomized, controlled phase 3 clinical trial (UNCOVER-3)
  publication-title: J Am Acad Dermatol
  doi: 10.1016/j.jaad.2017.06.153
  contributor:
    fullname: Blauvelt
– volume: 71
  start-page: 367
  year: 2019
  ident: 10.1016/j.adengl.2019.12.016_bib0045
  article-title: Safety of ixekizumab in patients with psoriatic arthritis: results from a pooled analysis of three clinical trials
  publication-title: Arthritis Care Res (Hoboken)
  doi: 10.1002/acr.23738
  contributor:
    fullname: Mease
SSID ssj0001213531
Score 2.2640188
SourceID crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 473
Title Switching From One Anti-IL-17 Antibody to Another: On Trying Again or Changing the Target
URI https://dx.doi.org/10.1016/j.adengl.2019.12.016
https://www.ncbi.nlm.nih.gov/pubmed/33307013
Volume 112
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NS8MwFA9jgngRv50fIwevcUvTNK23MRybunnYBvNU0iYdFWxHqYgX_3Zf0lb0ouAtvCZteM37SPL7JQhdub6KJE8EcXXiwAQl9ojk2iVcxzRx_djn2rCRpzNvvHTvVnzVQsOGC2NglbXvr3y69da1pFdrs7dJ096cmpPYIZ451M7LDaPchWAEY_r6g35bZzE3O1THpsKEyTRoGHQW5iXBvNdmD4IGdl3QXHz-a4T6Fn5Ge2i3zhvxoOraPmrp7ABtT-ud8UP0NH9LS4uLxKMif8GPmcaDrEzJ5IFQYYtRrt5xmUPZsq5uoA5eFIbmhAdrmWY4L7AlGxgJ1MALixI_QsvR7WI4JvW1CSSG7KgkUjt9RQMRRDKmMViVZJSpQCTKCxwtpc9oQr1Iasa0FwdcKO56ia-0wyBgej47Ru0sz_QpwppzHgnzGMy27yWBUrFrgnzkCwGZUweRRlXhpjodI2xgY89hpdrQqDakTgjCDhKNPsMffzkEB_5Hy5NK_V_fYcy4K8rO_v3Oc7TjGISKhS9eoHZZvOpLSDHKqGvHUBdtDSb349knP0nNYQ
link.rule.ids 315,786,790,4521,24144,27957,27958,45620,45714
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NS8MwFA9zgnoRv52fOXiNW5qmab2N4dh0m4dtME8hbdJRwXaUinjxbzdJW5kXBW8hTdrya99Hkt97D4Ab15ehoDFDroodvUCJPCSochFVEY5dP_KpMtHI44k3mLsPC7pogF4dC2NolZXuL3W61dZVT7tCs71KkvYUm0zs2p452K7L2QbYNO68qd9w-4nXNlpMaYcyb6peMZkZdQid5XkJLd9LcwiBA7sxaCqf_2qi1uxPfw_sVo4j7Jbvtg8aKj0AW-PqaPwQPE_fk8ISI2E_z17hU6pgNy0SNBwhzGwzzOQHLDLdtmFXd3oMnOUmzgl2lyJJYZZDG21gevQIOLM08SMw79_PegNU1U1AkXaPCiSU05E4YEEoIhxpsRIEExmwWHqBo4TwCY6xFwpFiPKigDJJXS_2pXKItpieT45BM81SdQqgopSGzFzWctvx4kDKyDVWPvQZ02C3AKqh4qsyPQaveWMvvISWG2g5drjubAFW48l_fGauNfgfM09K-L-fQ4jRV5ic_fue12B7MBuP-Gg4eTwHO46hq1gu4wVoFvmbutT-RhFe2f_pCy2RzvM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Switching+From+One+Anti-IL-17+Antibody+to+Another%3A+On+Trying+Again+or+Changing+the+Target&rft.jtitle=Actas+dermo-sifiliogr%C3%A1ficas+%28English+ed.%29&rft.au=Pinilla+Mart%C3%ADn%2C+B.&rft.au=S%C3%A1nchez+Vel%C3%A1zquez%2C+A.&rft.au=Vico+Alonso%2C+C.&rft.au=Rivera+D%C3%ADaz%2C+R.&rft.date=2021-05-01&rft.pub=Elsevier+Espa%C3%B1a%2C+S.L.U&rft.issn=1578-2190&rft.eissn=1578-2190&rft.volume=112&rft.issue=5&rft.spage=473&rft.epage=475&rft_id=info:doi/10.1016%2Fj.adengl.2019.12.016&rft.externalDocID=S1578219021000937
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1578-2190&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1578-2190&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1578-2190&client=summon